Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Medical Devices

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

<< Previous

Bullboard Posts

Next >>

Post by schrodingerscaton May 17, 2020 10:53pm

157 Views

Post# 31041018

stem cells

ya stem cells,live stem cells not dead stem cells,these are the ones that are being used in those "trials".
guess what cells are in Amnioboost/Amniovisc/Amnioblast(Liventa) thats right non viable(dead) stem cells.

these products conform to US laws prior to covid-19 and as such contain no viable stem cells or any other viable cells.

i figure any trials using this stuff are going to be neutral or negative.
the other guys are using viable stem cells which was not legal prior to covid unless the donor is the recipient.

Guy will have to tell you they are not viable but he has never said it,he just says stem cells.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks